genedrive plc (AIM:GDR)
1.300
+0.075 (6.12%)
Jun 17, 2026, 3:44 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 19.67 million as of June 17, 2026. Its market cap has increased by 117.06% in one year.
Market Cap
19.67M
Enterprise Value
19.78M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
Market Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 19.67M, an increase of 68.53%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 19.67M | 118.32% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.03B |
| GSK plc | 77.84B |
| Haleon | 29.53B |
| Smith & Nephew | 9.60B |
| Arecor Therapeutics | 23.60M |
| Provexis | 23.46M |
| CelLBxHealth | 20.17M |
| IXICO | 19.08M |